Covariates | Overall survival HR (95%CI) | p Value |
---|---|---|
Age (< 65 vs. ≥ 65) | 1.418 (0.766–2.625) | 0.267 |
Gender (female vs. male) | 0.856 (0.471–1.556) | 0.610 |
BMI (< 25 vs. ≥ 25) | 1.495 (0.852–2.623) | 0.16 |
Histological grade | ||
 G1 | 1 |  |
 G2 | 1.369 (0.391–4.799) | 0.624 |
 G3 | 1.836 (0.528–6.383) | 0.339 |
 G4 | 3.431 (0.695–16.929) | 0.130 |
Clinical stage | ||
 Stage I/II | 1 |  |
 Stage III/IV | 0.995 (0.127–7.817) | 0.996 |
T stage | ||
 T1/2 | 1 |  |
 T3/4 | 2.176 (0.269–17.610) | 0.466 |
AFP (< 300 vs. ≥ 300) | 0.902 (0.469–1.736) | 0.758 |
Vascular invasion | ||
 None | 1 |  |
 Mico | 1.201 (0.616–2.340) | 0.590 |
 Macro | 3.322 (1.208–9.141) | 0.02 |
Risk (high vs. low) | 2.002 (1.051–3.812) | 0.035 |